Tag Archives: FDA

CCHR Calls on FDA to Require Updated Antidepressant Warnings After Research Finds Withdrawal Symptoms Are Common

Posted on November 25, 2024 by cchrstl

Withdrawal symptoms are experienced by nearly half of the people trying to quit antidepressants, even if tapered over several weeks, research finds. CCHR says prescribing information and medication guides do not adequately convey this widespread risk and calls on FDA to require updates. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , | Comments Off on CCHR Calls on FDA to Require Updated Antidepressant Warnings After Research Finds Withdrawal Symptoms Are Common

CCHR Calls on FDA to Update Antidepressant Information for Increased Risks of Stroke and Heart Disease

Posted on November 18, 2024 by cchrstl

New research finds antidepressants increase the risk of stroke, atrial fibrillation, heart failure and other cardiovascular events. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on CCHR Calls on FDA to Update Antidepressant Information for Increased Risks of Stroke and Heart Disease

CCHR Calls on FDA to Revise Guidance on Use of Antidepressants by Pregnant Women

Posted on November 11, 2024 by cchrstl

Recent research adds to medical literature indicating potential risks to newborns from pregnant women using antidepressants. Citizens Commission on Human Rights calls on the U.S. Food and Drug Administration to review the research and issue updated guidance. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on CCHR Calls on FDA to Revise Guidance on Use of Antidepressants by Pregnant Women

Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Posted on October 28, 2024 by cchrstl

Decades after sexual dysfunction caused by antidepressants was first reported to persist after patients stopped taking the drugs, how many people experience continuing sexual problems is still not known.  Citizens Commission on Human Rights calls on the FDA to address the issue without further delay.  Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , | Comments Off on Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act

Clozapine (Really?) for Schizophrenia

Posted on October 21, 2024 by cchrstl

Psychiatric drugs and psychiatric treatments are not workable. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , | Comments Off on Clozapine (Really?) for Schizophrenia

New Study Warns of High Dose “ADHD” Drugs Inducing Psychosis

Posted on October 14, 2024 by cchrstl

CCHR has documented psychosis and violent behavior linked to any dose of the drugs and wants them prohibited as a treatment for the 3.1 million American children put at risk by taking them. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , | Comments Off on New Study Warns of High Dose “ADHD” Drugs Inducing Psychosis

CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

Posted on September 2, 2024 by cchrstl

Evidence presented to the U.S. drug regulatory agency alleging sexual assault and suppression of adverse events in clinical trials of ecstasy raises urgent concerns about the safety of patients in psychedelic-assisted psychotherapy. Citizens Commission on Human Rights calls for public release of FDA investigation results. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Comments Off on CCHR Calls on FDA to Release Results of Investigation into Alleged Sexual Assault, Research Misconduct in Psychedelic Clinical Trials

CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

Posted on August 19, 2024 by cchrstl

The U.S. drug regulatory agency examined evidence presented by the company requesting approval for MDMA (ecstasy) and reports from experts examining that evidence before denying approval for the drug as mental health treatment. A medical journal has just retracted three MDMA therapy research papers for ethical violations. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , , | Comments Off on CCHR Commends FDA Decision: Psychedelic Drug Ecstasy Not Proven Safe or Effective Treatment for Traumatized Patients

CCHR Commends Congressional Action to Prevent Continued Use of Electrical Shocking Device

Posted on July 22, 2024 by cchrstl

Citizens Commission on Human Rights advocates banning an electrical shocking device used on autistic and disabled students at a Massachusetts institution. Congress removed wording from a current bill that would have allowed shocking to continue after an expected FDA ban of the device. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , | Comments Off on CCHR Commends Congressional Action to Prevent Continued Use of Electrical Shocking Device

CCHR Applauds California Supreme Court Decision Holding Electroshock Machine Manufacturer Liable for Brain Damage

Posted on July 15, 2024 by cchrstl

Court concluded that company’s failure to fully disclose risks of electroshock to a physician meant that the patient also did not know the risks before undergoing the procedure, which resulted in brain damage. Citizens Commission on Human Rights warns device has never been proven safe. Continue reading →

Posted in Big Muddy River Newsletter | Tagged , , , | Comments Off on CCHR Applauds California Supreme Court Decision Holding Electroshock Machine Manufacturer Liable for Brain Damage